New pill aims to slow kidney disease in IgA nephropathy patients
Disease control
Recruiting now
This study tests an experimental drug called STL303 for people with IgA nephropathy, a kidney disease. About 15 adults will receive either STL303 or a placebo to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Possible side effects include na…
Phase: PHASE2 • Sponsor: Sitala Bio LTD • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC